Skip to content
Brand AI

TETRAPHARM

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer

    Danish biopharmaceutical company TETRAPHARM appointed Rolf Sass Sørensen as Chief Executive Officer, effective 6 October 2026. He succeeds co-founder Martin Rose, who together with co-founder Jesper Breum is leaving operational roles to pursue new biotech ventures while remaining shareholders in TETRAPHARM.

    Source